CalciMedica (CALC) Accumulated Expenses (2019 - 2023)
CalciMedica's (CALC) quarterly Accumulated Expenses came in at $758000.0 in Q1 2023, down 25.25% YoY from $1.0 million in Q1 2022, and up 2005.56% on a QoQ basis from $36000.0 in Q4 2022.
CalciMedica (CALC) Accumulated Expenses (2019 - 2023) Analysis & Trends
CalciMedica (CALC) has 5 years of Accumulated Expenses data on file, last reported at $758000.0 in Q1 2023.
- Quarterly Accumulated Expenses fell 25.25% year-over-year to $758000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $758000.0 (down 25.25% YoY) and the FY2022 annual result came in at $36000.0, down 88.16% from the prior year.
- Accumulated Expenses grew to $758000.0 in Q1 2023, from $36000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $2.3 million in Q4 2019 to a low of $36000.0 in Q4 2022.
- A 5-year average of $1.0 million and a median of $1.0 million in 2022 frame the typical range for Accumulated Expenses.
- The widest YoY moves for Accumulated Expenses: up 290.91% in 2022, down 88.16% in 2022.
- Tracing CALC's Accumulated Expenses over 5 years: stood at $2.3 million in 2019, then tumbled by 41.88% to $1.4 million in 2020, then sank by 77.58% to $304000.0 in 2021, then sank by 88.16% to $36000.0 in 2022, then soared by 2005.56% to $758000.0 in 2023.
- The last three Accumulated Expenses figures came in at $758000.0 (Q1 2023), $36000.0 (Q4 2022), and $1.0 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 758,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 304,000.00 |
| Sep 30, 2021 | 264,000.00 |
| Jun 30, 2021 | 396,000.00 |
| Mar 31, 2021 | 2.10 Mn |
| Dec 31, 2020 | 1.36 Mn |
| Sep 30, 2020 | 1.56 Mn |
| Dec 31, 2019 | 2.33 Mn |